Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,343 shares at $459.83 ($1.5M) on 2025-02-11, disclosed to the SEC on 2025-02-12.
Scheduled sale ($1.5M) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $467.98 | 591 | $277K | 17.9% |
| 2 | $459.83 | 1,376 | $633K | 41.0% |
| 3 | $459.83 | 1,376 | $633K | 41.0% |
| Total | $461.27 avg | 3,343 | $1.5M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |